semaglutide and thyroid cancer risk New Research Challenges Fears of Semaglutide-Linked New study finds weight loss

Contribuye al seguimiento de programas de control de peso

R., Pacheco-Tena, C

The neurological disorder associated with thyroid autoimmunity

Healthy aging with GlyNAC The worlds population is aging rapidly by 2050, more than 20% of people will be over 60 (WHO, 2024)

If you are curious about how semaglutide compares to other compounds sometimes discussed in similar regulatory contexts, the breakdown of semaglutide vs tirzepatide is worth reading

Prez-Velasco MA, Bernal-Lpez MR, Trenas A, Ricci M, Lpez-Carmona MD, Garca de Lucas MD, Gmez-Huelgas R, Prez-Belmonte LM (2025) Efficacy of once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes